Skip to content
LexBuild

Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Ethics Subcommittee (ES)

---
identifier: "/us/fr/2010-29774"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Ethics Subcommittee (ES)"
title_number: 0
title_name: "Federal Register"
section_number: "2010-29774"
section_name: "Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Ethics Subcommittee (ES)"
positive_law: false
currency: "2010-11-26"
last_updated: "2010-11-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2010-29774"
document_type: "notice"
publication_date: "2010-11-26"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "75 FR 72831"
fr_volume: 75
---

#  Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)—Ethics Subcommittee (ES)

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the CDC announces the following meeting of the aforementioned subcommittee:

*Time and Date:* 2 p.m.—3:30 p.m. Eastern Standard Time, January 4, 2011.

*Place:* Teleconference.

*Status:* Open to the public, limited only by availability of telephone ports. The public is welcome to participate during the public comment period. A public comment period is tentatively scheduled from 3 p.m.—3:15 p.m. To participate in the teleconference, please dial 1-877-928-1204 and enter conference code 4305992.

*Purpose:* The ES will provide counsel to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners.

*Matter to be Discussed:* The ES will discuss a strategy for addressing its charge to provide a preliminary overview to the ACD on ethical issues related to non-communicable disease prevention and control and an ethics framework to guide CDC programs and activities.

The agenda is subject to change as priorities dictate.

*Contact Person for More Information:* Drue Barrett, Ph.D., Designated Federal Officer, ACD, CDC—ES, CDC, 1600 Clifton Road, NE., M/S D-50, Atlanta, Georgia 30333. Telephone (404) 639-4690. E-mail: *[email protected].*

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: November 18, 2010.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.